Mycobacterium lepraeinduces a tolerogenic profile in monocyte-derived dendritic cells via TLR2 induction of IDO
Open Access
- 11 October 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 110 (1) , 167-176
Abstract
The enzyme IDO‐1 is involved in the first stage of tryptophan catabolism and has been described in both microbicidal and tolerogenic microenvironments. Previous data from our group have shown that IDO‐1 is differentially regulated in the distinctive clinical forms of leprosy. The present study aims to investigate the mechanisms associated with IDO‐1 expression and activity in human monocyte‐derived dendritic cells (mDCs) after stimulation with irradiated Mycobacterium leprae and its fractions. M. leprae and its fractions induced the expression and activity of IDO‐1 in human mDCs. Among the stimuli studied, irradiated M. leprae and its membrane fraction (MLMA) induced the production of proinflammatory cytokines TNF and IL‐6 whereas irradiated M. leprae and its cytosol fraction (MLSA) induced an increase in IL‐10. We investigated if TLR2 activation was necessary for IDO‐1 induction in mDCs. We observed that in cultures treated with a neutralizing anti‐TLR2 antibody, there was a decrease in IDO‐1 activity and expression induced by M. leprae and MLMA. The same effect was observed when we used a MyD88 inhibitor. Our data demonstrate that coculture of mDCs with autologous lymphocytes induced an increase in regulatory T (Treg) cell frequency in MLSA‐stimulated cultures, showing that M. leprae constituents may play opposite roles that may possibly be related to the dubious effect of IDO‐1 in the different clinical forms of disease. Our data show that M. leprae and its fractions are able to differentially modulate the activity and functionality of IDO‐1 in mDCs by a pathway that involves TLR2, suggesting that this enzyme may play an important role in leprosy immunopathogenesis.Keywords
This publication has 35 references indexed in Scilit:
- Tumor necrosis factorCancer Letters, 2013
- Indoleamine 2,3-Dioxygenase and Dendritic Cell TolerogenicityImmunological Investigations, 2012
- M. tuberculosis Induces Potent Activation of IDO-1, but This Is Not Essential for the Immunological Control of InfectionPLOS ONE, 2012
- Increased Expression of Regulatory T Cells and Down-Regulatory Molecules in Lepromatous LeprosyThe American Journal of Tropical Medicine and Hygiene, 2012
- The role of indoleamine 2, 3-dioxygenase in lepromatous leprosy immunosuppressionClinical and Experimental Immunology, 2011
- The innate immune response in leprosyCurrent Opinion in Immunology, 2010
- Mannose‐capped lipoarabinomannan‐ and prostaglandin E2‐dependent expansion of regulatory T cells in human Mycobacterium tuberculosis infectionEuropean Journal of Immunology, 2008
- Toll-like receptor 2 signaling modulates the functions of CD4+CD25+regulatory T cellsProceedings of the National Academy of Sciences, 2006
- The Continuing Challenges of LeprosyClinical Microbiology Reviews, 2006
- TheMycobacterium tuberculosis19-Kilodalton Lipoprotein Inhibits Gamma Interferon-Regulated HLA-DR and FcγR1 on Human Macrophages through Toll-Like Receptor 2Infection and Immunity, 2003